2',5'-Dideoxyadenosine
CAS No. 6698-26-6
2',5'-Dideoxyadenosine( —— )
Catalog No. M22179 CAS No. 6698-26-6
2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 80 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 211 | In Stock |
|
| 50MG | 346 | In Stock |
|
| 100MG | 551 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1200 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2',5'-Dideoxyadenosine
-
NoteResearch use only, not for human use.
-
Brief Description2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively.
-
Description2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively [2]. 2',5'-Dideoxyadenosine (10 μM, 30 min) reduces cAMP production and blocks the phosphorylation of GluA1 at Ser845 induced by carbachol (CCh). 2',5'-Dideoxyadenosine (10 μM, 30 min) blocks CCh-induced increase of phosphorylation of Akt and attenuates CCh-induced phosphorylation of Ser2448 [3].2',5'-Dideoxyadenosine (0.1 mg/kg; i.p.; 15 min pre-treated) fully inhibits the natriuretic, diuretic and K+ and Cl- sparing effect of FrEtOAc in rats.
-
In VitroWestern Blot Analysis Cell Line:Primary hippocampal neurons Concentration:10 μM Incubation Time:30 min Result:Reduced cAMP production and blocked the phosphorylation of GluA1 at Ser845 induced by carbachol (CCh).
-
In VivoAnimal Model:Male Wistar rats (3-4 months old)Dosage:0.1 mg/kg Administration:IP; 15 min pre-treated Result:Fully inhibited the diuretic, natriuretic and K+ and Cl- sparing effect of Fr?EtOAc in rats.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAdenylyl cyclase (AC)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6698-26-6
-
Formula Weight235.24
-
Molecular FormulaC10H13N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (531.37 mM)
-
SMILESC[C@H]1O[C@H](C[C@@H]1O)n1cnc2c(N)ncnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
4,4-di(4-hydroxy-3-m...
4,4-di(4-Hydroxy-3-methoxyphenly)-2,3-dimethylbutanol has antioxidant and potential cytotoxic abilities, it also shows inhibition against HIV-1 integrase.
-
KRN5
KRN5 has potential to treat NFAT5-mediated Chronic Arthritis. KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC50 of 750 nM.
-
PACAP-38 (28-38) (hu...
PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
Cart
sales@molnova.com